Life science–based technical innovations irrevocably alter the method by which care is delivered and by which standards of quality are measured. Minimally invasive catheter and surgical techniques, the explosion in molecular medicine, personalized approaches to chemotherapeutic monitoring and dosing, and a deep understanding of the cell signaling pathways that influence inflammation, healing, oncogenesis, metabolic syndrome, and so on are but a few of the examples of areas in which care has been significantly advanced by progressive science and the commercial and technologic reduction to practice necessary for innovation to reach the bedside. Many individual physicians and scientists may contribute prominently to this progress through the generation of the primary idea or through a more direct contribution on an entrepreneurial level assuming a role of advisor or central part of the management team. This necessitates interacting with sources of funding, for example, the venture capital community, the strategic investment community (pharmaceutical and device companies), and the public markets. Planning the growth of an idea from seed stage to commercialization is greatly facilitated by knowledge of these market dynamics and, although the physician-scientist is not often in a lead business role, the marriage of technology and commercial insights offers the best chance for ultimate success in helping patients and creating value.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Accepted: November 27, 2007
Leerink Swann LLC is a full-service investment banking firm that offers institutional sales, healthcare equity research, institutional trading, corporate finance, and asset management services for high-net-worth clients. Member FINRA/SIPC.
© 2008 Mosby, Inc. Published by Elsevier Inc. All rights reserved.